Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT05411094 |
Title | Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer |
Recruitment | Suspended |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | National Cancer Institute (NCI) |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Los Angeles General Medical Center | Los Angeles | California | 90033 | United States | Details | |
USC / Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | United States | Details | |
UC Irvine Health/Chao Family Comprehensive Cancer Center | Orange | California | 92868 | United States | Details | |
University of Michigan Comprehensive Cancer Center | Ann Arbor | Michigan | 48109 | United States | Details | |
University of Michigan - Brighton Center for Specialty Care | Brighton | Michigan | 48116 | United States | Details | |
UNC Lineberger Comprehensive Cancer Center | Chapel Hill | North Carolina | 27599 | United States | Details | |
Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | United States | Details | |
University of Wisconsin Carbone Cancer Center | Madison | Wisconsin | 53792 | United States | Details | |
University Health Network-Princess Margaret Hospital | Toronto | Ontario | M5G 2M9 | Canada | Details |